About this trial
The main purpose of this study is to pioneer an easy risk stratification tools, which is developed using novel artificial intelligence (AI) algorithms, that will be able to detect common and fatal heart diseases easily simply through a picture of the back of the eye, the retina. The retinal images will be analysed using a computer application with the risk stratification tool to predict health outcome of individual. The study also aims to correlate between clinical characteristics, lifestyle (eg. exercise, sleep, erectile dysfunction) and diet to retinal and coronary vasculature and clinical outcomes.
Eligibility criteria
Qualifiers
21 years of age or older
Sufficient language skills in English or Chinese
Provided informed consent
Completed CTCA or CT CAC in the past 6 months.
Disqualifiers
Patients whose informed consent was not obtained.
Age <21 years old
Patients with cardiac event (acute myocardial infarction, Stroke, heart failure, angina requiring hospitalization) and/or coronary revascularization (percutaneous coronary intervention (PCI) and/or coronary artery bypass grafting (CABG) prior to CTCA
Patient whose informed consent was not obtained.
Trial design
Treatments tested in this trial
- Ocular Imaging
- Questionnaires
Treatment groups
Sponsors and collaborators
National Heart Centre Singapore
Lead sponsor
Singapore Eye Research Institute
Collaborator